epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

turmeric (Curcuma longa)

common name

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • acne [Insufficient Evidence]
  • acral erythema, chemo-induced [Insufficient Evidence]
  • allergic rhinitis [Possibly Effective]
  • Alzheimer disease [Possibly Ineffective]
  • amenorrhea [Insufficient Evidence]
  • ankylosing spondylitis [Insufficient Evidence]
  • anxiety [Insufficient Evidence]
  • aphthous ulcer (canker sores) [Insufficient Evidence]
  • arthralgia, aromatase inhibitor-induced [Insufficient Evidence]
  • asthma [Insufficient Evidence]
  • athletic performance [Insufficient Evidence]
  • back pain [Insufficient Evidence]
  • bacterial vaginosis [Insufficient Evidence]
  • beta-thalassemia [Insufficient Evidence]
  • BPH [Insufficient Evidence]
  • bruising [Insufficient Evidence]
  • CABG [Insufficient Evidence]
  • cachexia [Insufficient Evidence]
  • carpal tunnel syndrome [Insufficient Evidence]
  • CKD [Insufficient Evidence]
  • cognitive decline, age-related [Insufficient Evidence]
  • colorectal adenoma [Insufficient Evidence]
  • colorectal CA [Insufficient Evidence]
  • constipation, chemo-induced [Insufficient Evidence]
  • COVID-19 [Insufficient Evidence]
  • Crohn disease [Insufficient Evidence]
  • denture stomatitis [Insufficient Evidence]
  • depression [Possibly Effective]
  • diabetes mellitus [Insufficient Evidence]
  • diabetic foot ulcer [Insufficient Evidence]
  • diabetic nephropathy [Insufficient Evidence]
  • diarrhea, chemo-induced [Insufficient Evidence]
  • dry eye disease [Insufficient Evidence]
  • dysmenorrhea [Insufficient Evidence]
  • dyspepsia [Possibly Effective]
  • endometriosis [Insufficient Evidence]
  • erythema [Insufficient Evidence]
  • exercise-induced muscle damage [Insufficient Evidence]
  • exercise-induced muscle soreness [Insufficient Evidence]
  • gingivitis [Insufficient Evidence]
  • gout [Insufficient Evidence]
  • Gulf war syndrome [Insufficient Evidence]
  • H. pylori infection [Insufficient Evidence]
  • hearing loss [Insufficient Evidence]
  • HTN [Insufficient Evidence]
  • hyperlipidemia [Possibly Effective]
  • IBS [Insufficient Evidence]
  • impaired glucose tolerance [Insufficient Evidence]
  • joint pain [Insufficient Evidence]
  • juvenile idiopathic arthritis [Insufficient Evidence]
  • knee pain [Insufficient Evidence]
  • lichen planus [Insufficient Evidence]
  • metabolic dysfunction-associated steatotic liver disease [Possibly Effective]
  • metabolic syndrome [Insufficient Evidence]
  • MI [Insufficient Evidence]
  • migraine prophylaxis [Insufficient Evidence]
  • nausea/vomiting, chemo-induced [Insufficient Evidence]
  • neuropathy, vincristine-induced [Insufficient Evidence]
  • obesity [Insufficient Evidence]
  • oral mucositis, chemo- or XRT-related [Possibly Effective]
  • oral submucous fibrosis [Insufficient Evidence]
  • osteoarthritis [Possibly Effective]
  • pain, acute [Insufficient Evidence]
  • peptic ulcer [Possibly Ineffective]
  • periodontitis [Insufficient Evidence]
  • peripheral neuropathy, chemo-induced [Insufficient Evidence]
  • physical performance [Insufficient Evidence]
  • polycystic ovary syndrome [Insufficient Evidence]
  • postmenopausal conditions [Insufficient Evidence]
  • postop pain [Insufficient Evidence]
  • postpartum depression [Insufficient Evidence]
  • premenstrual syndrome [Insufficient Evidence]
  • prostate CA [Insufficient Evidence]
  • pruritus [Possibly Effective]
  • psoriasis [Insufficient Evidence]
  • quality of life [Insufficient Evidence]
  • radiation dermatitis [Insufficient Evidence]
  • radiation proctopathy [Insufficient Evidence]
  • respiratory infections [Insufficient Evidence]
  • rheumatoid arthritis [Insufficient Evidence]
  • sarcopenia [Insufficient Evidence]
  • schizophrenia [Insufficient Evidence]
  • sepsis [Insufficient Evidence]
  • SLE [Insufficient Evidence]
  • smoking cessation [Insufficient Evidence]
  • stress [Insufficient Evidence]
  • stroke [Insufficient Evidence]
  • tuberculosis [Insufficient Evidence]
  • ulcerative colitis [Insufficient Evidence]
  • uveitis [Insufficient Evidence]
  • wound healing [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information